NIGERIA NEUROPATHIC PAIN MANAGEMENT DRUGS MARKET ANALYSIS

Nigeria Neuropathic Pain Management Drugs Market, by Drug Class (Anticonvulsants, Serotonin–norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), and Others), by Disease Condition (Diabetic Neuropathy, Chemotherapy-induced Peripheral Neuropathy, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Feb 2022
Code : CMI4918
Pages :154
Formats :
Excel and PDF
Industry : Pharmaceutical

Nigeria Neuropathic Pain Management Drugs MarketSize and Trends

The Nigeria neuropathic pain management drugs market is estimated to be valued at US$ 8.1 million in 2021 and is expected to exhibit a CAGR of 3.2% over the forecast period (2021-2028).

Figure 1. Nigeria Neuropathic Pain Management Drugs Market Share (%), By Drug Class, 2021

The emerging opportunity for local production of neuropathic pain management drugs in the market is expected to drive growth of the Nigeria neuropathic pain management drugs market over the forecast period.

Presence of branded as well as generic versions of drugs for the treatment of neuropathic pain is expected to drive the market growth over the forecast period.

Nigeria Neuropathic Pain Management Drugs Market– Impact of Coronavirus (Covid-19) Pandemic

Figure 2. Nigeria Neuropathic Pain Management Drugs Market Share (%), By Disease Indication, 2021